Compare
Abbott Laboratories vs Bruker (ABT vs BRKR)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Bruker (BRKR) +52.5%; so far this year the figures are -12.3% and +30.1%.
Abbott Laboratories is the larger company by market value, about 20.4 times the size of Bruker.
Revenue grew +10.0% at ABT and +2.2% at BRKR over the last year.
ABT yields 2.29%. BRKR yields 0.33%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | BRKR | |
|---|---|---|
| Price | $109.93 | $61.31 |
| 1-day | -3.23% | +5.60% |
| YTD | -12.26% | +30.14% |
| 1 year | -11.73% | +52.51% |
| 3 years | +15.70% | +7.54% |
| Market cap | $190.4B | $9.3B |
| P/E | 40.9 | — |
| P/S | 3.95 | 2.66 |
| P/B | 3.73 | 4.05 |
| Revenue growth | +10.00% | +2.20% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 47.7 |
| Net margin % | 9.7 | -3.5 |
| ROE % | 9.2 | -5.4 |
| Debt / equity | 0.61 | 0.74 |
| FCF yield % | 3.5 | 2.6 |
| Dividend yield % | 2.29 | 0.33 |
| Beta | 0.06 | 1.65 |
| RSI (14) | 58.5 | 53.9 |
| Technical rating |